Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The strange double life of Dab2

10.01.2017

Cancer protein also plays role in fat storage

Sometimes proteins do a lot more than we expect. Dab2, for example, has long been linked to cancer. The molecule is associated with a chain of signaling proteins called the Ras-MAPK pathway. In many cancers, elements of Ras-MAPK mutate and start telling cells to grow uncontrollably.


These are Dab2 (red)-positive pre-adipocytes accumulating lipid droplets (green).

Credit: Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center researcher Xiang-Xi Michael Xu, Ph.D., who is also a professor of cell biology at the University of Miami Miller School of Medicine, discovered Dab2 more than 20 years ago and has been studying its relationship to cancer ever since. But now he's found that Dab2 has been living a secret life all along - one that could have public health implications for fighting obesity. In a paper published in the journal Scientific Reports, the Xu lab has shown that young mice without Dab2 don't gain weight when given excessive food.

"These mice look and act normal," says Xu. "Everything seems fine, except when we give them a high-fat diet. They just don't get fat."

The underlying mechanism may revolve around fat stem cells: immature cells that can either divide into more stem cells or differentiate into mature fat cells. In normal mice, Dab2 suppresses Ras-MAPK, which in turn elevates a protein called PPAR, which helps fat stem cells make the jump to mature fat cells. Eliminating Dab2 short-circuits that process.

While normal mice eating a calorie-dense diet pack on weight, the Dab2 knockouts stay lean - but only for a while. As the mice mature, the metabolic effect dissipates. By six months, the loss of Dab2 has virtually no effect.

Xu believes this happens because mice (and humans) lose their fat stem cells as they reach maturity. This early impact could help explain why early weight problems could persist into adulthood and many adults have such a hard time losing weight.

"Dab2 controls a population of fat stem cells that slowly disappears," said Xu. "It seems that children are especially affected by diet. They can both increase fat cell number and fat cell size when they are young. Later in life, they can still make fat, but that's existing fat cells getting bigger. Habits of childhood could be affecting adults, making them more susceptible to obesity."

From a public health standpoint, these findings may reinforce the importance of steering children away from high-fat diets. Identifying this role for Dab2 could also lead to new pharmaceutical strategies to combat childhood obesity, as the protein could make an attractive target for drug development.

"It would be very hard for a small laboratory like ours to develop a new drug that targets Dab2," said Xu. "But perhaps a pharmaceutical company will pick it up and develop it."

###

About Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center, part of UHealth - the University of Miami Health System and the University of Miami Miller School of Medicine, is among the nation's leading cancer centers and South Florida's only Cancer Center of Excellence. A 2015 study by Memorial Sloan Kettering Cancer Center, published in The Journal of the American Medical Association, showed that cancer patients treated at Sylvester have a 10 percent higher chance of survival than those treated at nearly any other cancer center in the nation.

With the combined strength of more than 120 cancer researchers and 130 cancer specialists, Sylvester discovers, develops and delivers more targeted therapies, providing the next generation of cancer clinical care - precision cancer medicine - to each patient. Our comprehensive diagnostics, coupled with teams of scientific and clinical experts who specialize in just one type of cancer, enable us to better understand each patient's individual cancer and develop treatments that target the cells and genes driving the cancer's growth and survival, leading to better outcomes.

At Sylvester, patients have access to more treatment options and more cancer clinical trials than most hospitals in the southeastern United States. To better serve current and future patients, Sylvester has a network of conveniently located outpatient treatment facilities in Miami, Kendall, Hollywood, Plantation, Deerfield Beach, Coral Springs, and Coral Gables. For more information, visit sylvester.org.

Media Contact

Patrick Bartosch
patrick.bartosch@med.miami.edu
305-243-8219

http://www.med.miami.edu/ 

Patrick Bartosch | EurekAlert!

More articles from Health and Medicine:

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Stiffness matters

22.02.2018 | Life Sciences

Magnetic field traces gas and dust swirling around supermassive black hole

22.02.2018 | Physics and Astronomy

First evidence of surprising ocean warming around Galápagos corals

22.02.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>